Is USANA Health Sciences Inc (USNA) overvalued? · P/E 18, rev $854.5M
USANA Health Sciences Inc (USNA) is a packaged foods company listed on US.
This page asks whether USANA Health Sciences Inc (USNA) looks expensive on cached numbers — not a short thesis.
Latest reported USNA revenue for 2024-12-28 was $854.5M. Net income was $42.1M. Revenue was down 7.2% from 2023-12-30 to 2024-12-28. USNA currently screens at market cap $610.3M and trailing P/E 18.0.
USNA currently screens at market cap $610.3M and trailing P/E 18.0. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next USNA 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the USNA stock page for the full model, not this heading.
Not investment advice.